New appointment at Cyprotex
This article was originally published in Scrip
Cyprotex, a UK-based drug discovery technology and information company, has named Ben Butterfield executive director for business development in North America. The appointment follows Cyprotex's restructuring of its US and rest of world sales activities. Mr Butterfield was previously business development manager at Toxikon, which provides preclinical safety research to medical device and pharmaceutical companies.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”